![]() |
|
Watch this webinar and hear from Exothera’s chief technology officer, Dr. Hanna P. Lesch as she explains their scale-up journey of adding a large-scale, suspension-based manufacturing platform, from upstream through downstream processing of viral vectors of up to 2,000 L.
|